Article thumbnail
Location of Repository

Use of evidence-based pharmacotherapy after myocardial infarction in Estonia

By Toomas Marandi, Aleksei Baburin and Tiia Ainla
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2911401
Provided by: PubMed Central

Suggested articles

Citations

  1. (2007). Alter DA: Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA
  2. (2007). B: ACC/AHA
  3. (2005). Bassand JP: Compliance with guidelines and 1-year mortality in patients with acute myocardial infarction: a prospective study. Eur Heart J
  4. (2006). clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey. Eur Heart J
  5. (2004). Comparison of management and 30-day mortality of acute myocardial infarction in men versus women in Estonia. Acta Cardiol
  6. (2006). Diagnosis and treatment of acute myocardial infarction in tertiary and secondary care hospitals in Estonia.
  7. (2006). Euro Heart Survey Investigators: The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with
  8. (2005). External validity of randomised controlled trials: "To whom do the results of this trial apply?". Lancet
  9. (2006). Granger CB: Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ
  10. (2009). Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-STReceived:
  11. (2008). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J
  12. (2004). Patient adherence: The next frontier in Quality Improvement.
  13. (2006). Peterson E: National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. Am Heart J
  14. (2003). Pilote L: Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Am Heart J
  15. (2002). Ruzyllo W: Management of acute coronary syndromes in patients presenting without persistent STsegment elevation. Eur Heart J
  16. (2007). SG: Optimal medical therapy at discharge in patients with acute coronary syndromes: Temporal changes, characteristics, and 1-year outcome. Am Heart J
  17. (2004). Steg PG: Adherence to evidencebased therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
  18. (2008). TA: Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm
  19. (2006). Torp-Pedersen C: Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J
  20. (2003). Verheugt FWA, Wijns W: Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.